A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery (Q41658726)
Jump to navigation
Jump to search
scientific article published on April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery |
scientific article published on April 2015 |
Statements
1 reference
A pilot study on reparixin, a CXCR1/2 antagonist, to assess safety and efficacy in attenuating ischaemia-reperfusion injury and inflammation after on-pump coronary artery bypass graft surgery (English)
1 reference
P Opfermann
U Derhaschnig
A Felli
J Wenisch
D Santer
A Zuckermann
M Dworschak
1 April 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference